New York City, NY -- (SBWIRE) -- 12/12/2013 -- StockMarketIntel.com issues a special report on the following stocks: MAKISM 3D CORP (OTCBB:MDDD), Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA), Himax Technologies, Inc. (ADR) (NASDAQ:HIMX), Avanir Pharmaceuticals Inc (NASDAQ:AVNR)
MAKISM 3D CORP (OTCBB:MDDD) gained 47.98%, trading on 7.95 million shares, to end the trade at $1.28. The stock changed hands in a range of $0.87 to $1.60, bringing its market capitalization to about $51.90 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.41 and was moved to the maximum level of $6.00. Makism 3D Corp., Inc. designs and manufactures 3D printers for organizations and individuals primarily in the United Kingdom. The company?s products include professional and consumer grade 3D printers; and additive manufacturing materials. The company offers its products for educational and professional organizations, offices, and home users.
Will MDDD Continue To Move Higher? Find Out Here
Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA) declined -3.02%, to complete the trading session at $2.57, with a total volume of 8.24 million shares. The stock, on average, trades on a volume of 29.74 million shares. It floated in a range of $2.55 to $2.70 during the last trading session, with a beta value of 3.44. Its market capitalization now moved to about $2.98 billion. In the past 52 weeks, the share price has not declined below $0.25 and above $5.44. Federal National Mortgage Association (Fannie Mae) provides liquidity and stability support services in the secondary mortgage market in the United States. The company securitizes mortgage loans originated by lenders in the primary mortgage market into Fannie Mae mortgage-backed securities (Fannie Mae MBS).
Has FNMA Found The Bottom And Ready To Gain Momentum? Find Out Here
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) recorded a gain of 1.10% and was in a range of $10.85-$11.45 before closing at $11.14. The stock completed the day with a total volume of 15.60 million shares, versus an average volume of 6.56 million shares. The share price hit its 52-week low of $2.25 and $11.49 was the best price. Himax Technologies, Inc. designs, develops, and markets semiconductors for flat panel displays. The company operates in two segments, Driver IC and Non-Driver Products. Its principal products include display drivers and timing controllers for large-sized thin film transistor liquid crystal display (TFT-LCD) panels that are used in desktop monitors, notebook computers, and televisions; and display drivers and timing controllers for small and medium-sized TFT-LCD panels, which are used in mobile handsets and consumer electronics products, such as tablet PCs, netbook computers, digital cameras, mobile gaming devices, portable DVD players, digital photo frames, head-mounted-displays, and car navigation displays.
Why Should Investors Buy HIMX After The Recent Gain? Just Go Here and Find Out
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) declined -29.84% yesterday, bringing its market capitalization around $437.86 million. The share price, after opening at $3.46, made a high of $3.65 and hovered above $3.00 to end the day at $3.01. The total number of shares that changed hands during the session was 14.28 million shares, as compared to average trading volume of 1.72 million shares. Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. It primarily offers NUEDEXTA, a proprietary combination of dextromethorphan and low-dose quinidine for the treatment of pseudobulbar affect; and Docosanol 10% cream, an over-the-counter product for the treatment of cold sores.
Why Should Investors Buy AVNR After the Recent Fall? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)